Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexaria Bioscience Corp LEXX

Alternate Symbol(s):  LEXXW

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company's patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting more effective oral delivery. DehydraTECH has also evidenced an ability to deliver some drugs effectively across the blood brain barrier. It is advancing several research and development (R&D) activities in both preclinical and clinical programs. Its primary research programs are the investigation of optimal formulations of DehydraTECH-enhanced glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drugs as well as the investigation of cannabidiol (CBD) for the reduction of hypertension leading to a cleared IND application by the United States Food and Drug Administration. It operates a licensed in-house research laboratory and holds an intellectual property portfolio with around 46 patents granted and many patents pending worldwide.


NDAQ:LEXX - Post by User

Bullboard Posts
Post by shawkon Dec 09, 2017 8:51pm
198 Views
Post# 27125157

New Rules Benefit LXX

New Rules Benefit LXXhttps://cannabisnow.com/new-cannabis-contraband-brands-products-now-outlawed-californias-new-rules/
Extremely important edible rules favorable to Lexaria. If you don't have absorption tech. then your edible product just won't sell. Negotiations underway with 10+ producers!! 

The biggest changes are to edibles, and one of the most significant limits is on serving sizes. Will we have to say goodbye to Slactavis’s 1500 mg bottles of syrup, 1000 mg bags of Bomb Chips, Kiva’s 180 mg chocolate bars, and Korova’s 300 mg popcorn bags? Quite possibly, yes. 

According to the Bureau of Cannabis Control: “Beginning January 1, 2018, licensees shall not transport or sell any edible cannabis product that exceeds 10 milligrams per serving. Adult-use products may not exceed 100 milligrams per package; however, medicinal cannabis products may exceed 100 milligrams per package.” 

Seems pretty clear-cut. At the same time, in the same breath, the bureau says it will allow retailers to “sell cannabis products that do not meet the THC limits per package established by the state Department of Public Health” during the six-month transition period. 

Whether the edible dose limits drop on Jan. 1 or July 1, THC limits are a significant disruption to most dispensaries’ edibles menus, which are full of products much, much stronger than 100 mg. It appears that as long as products above 100 mg are sold on the medical cannabis market, and as long as they’re somehow clearly identified as products with many multiple serving sizes, they may be allowed. Don’t throw away your medical marijuana recommendation anytime soon — but it gets worse.
 
Bullboard Posts